Literature DB >> 26363924

Gender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer's Disease.

Zhou Yang1, Allan Levey2.   

Abstract

BACKGROUND: Gender is one of the best-established differences in risk for Alzheimer's disease (AD) and other forms of dementia, with women being at greater risk. However, the financial implications are unknown. This study aims at understanding the economic burden of AD by gender.
METHOD: This study takes a life-time perspective to investigate the burden of AD over the course of the disease. Nationally representative Medicare Current Beneficiary Survey data were used to estimate the course of illness of AD from age 65 to death and the incremental costs of AD on Medicare and Medicaid. Published data on the use and costs of assisted living facilities, home health care, and informal care were imputed into the course of illness to calculate the lifetime costs of these services.
RESULTS: Females and males have distinctively different patterns of course of illness of AD. Women face higher risks of having AD (15.5% vs. 13.1%) and of serving as informal caregivers for AD patients (6.8% vs. 4.0%) before death. Medicare and Medicaid account for major payers of AD care for both genders, but the greatest economic challenge of AD to women is the cost of the informal care they deliver, resulting in women bearing six times the cost of men.
CONCLUSION: Public policy interventions that aim at curing or slowing the progress of AD will greatly benefit the welfare and economic status of women.
Copyright © 2015 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26363924     DOI: 10.1016/j.whi.2015.06.001

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  8 in total

1.  Alzheimer Disease and Related Disorders and Out-of-Pocket Health Care Spending and Burden Among Elderly Medicare Beneficiaries.

Authors:  Nilanjana Dwibedi; Patricia A Findley; Constance Wiener R; Chan Shen; Usha Sambamoorthi
Journal:  Med Care       Date:  2018-03       Impact factor: 2.983

Review 2.  Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.

Authors:  Arijita Deb; James Douglas Thornton; Usha Sambamoorthi; Kim Innes
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2017-04       Impact factor: 2.217

3.  Gender effects on components of burden and depression among dementia caregivers.

Authors:  Sarah Pillemer; Jennifer Davis; Geoffrey Tremont
Journal:  Aging Ment Health       Date:  2017-06-12       Impact factor: 3.658

4.  Medicare expenditures attributable to dementia.

Authors:  Lindsay White; Paul Fishman; Anirban Basu; Paul K Crane; Eric B Larson; Norma B Coe
Journal:  Health Serv Res       Date:  2019-03-13       Impact factor: 3.402

5.  How does the onset of physical disability or dementia in older adults affect economic wellbeing and co-payments for health care? the impact of gender.

Authors:  Yanan Hu; Prudence R Carr; Danny Liew; Jonathan Broder; Emily J Callander; John J McNeil
Journal:  BMC Health Serv Res       Date:  2022-05-25       Impact factor: 2.908

6.  A Comprehensive Measure of the Costs of Caring for a Parent: Differences According to Functional Status.

Authors:  Norma B Coe; Meghan M Skira; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2018-09-17       Impact factor: 5.562

Review 7.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Authors:  Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060).

Authors:  Kumar B Rajan; Jennifer Weuve; Lisa L Barnes; Elizabeth A McAninch; Robert S Wilson; Denis A Evans
Journal:  Alzheimers Dement       Date:  2021-05-27       Impact factor: 16.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.